A tweet from Agnieszka Solberg, MD.

Cardiovascular Disease

Childhood Lp(a) Predicts Adult CVD Risk

Individuals who had high Lp(a) levels when they were young were twice as likely to develop atherosclerotic cardiovascular disease in middle age, a new study in Circulation reveals. 

Lp(a) levels are almost entirely genetic (as opposed to being dictated by lifestyle choices), and this new study underscores the value of measuring Lp(a) in childhood, rather than waiting till middle age to identify those most at-risk.

The authors examined Lp(a) data from the 1970s YFS study (n=3596), which investigated the determinants of CV disease in Finnish children, as well as data from the 1980s Bogalusa Heart Study (n=587) out of Tulane University.  

In the YFS analysis, the authors found that…

• Those with high childhood Lp(a) levels (defined as 30 mg/dL or higher) were about twice as likely to develop adult ASCVD (hazard ratio: 2.0).
  
• The risk of coronary heart disease and noncoronary atherosclerotic events were both similarly increased.
  

In the BHS analysis, researchers found that…

• Individuals with high childhood Lp(a) were 2.5 times more likely to develop adult ASCVD.
  
• The risk associated with Lp(a) remained the same, even after adjusting for BMI and LDL-C.

In neither study was Lp(a) in youth associated with increased carotid artery thickness in adulthood, which may suggest that elevated Lp(a) levels do not confer CV risk by contributing to early preclinical vasculopathy.

The generalizability of these findings is unclear. The results observed in the Finnish study were replicated with data exclusively from White participants in the BHS “because the original YFS included only White participants.” Cardiovascular risk is known to differ across racial/ethnic groups, causing risk equations to consistently underperform in Black adults. So take these findings with a grain of salt.  

The Takeaway

Elevated Lp(a) is a known atherosclerotic CVD risk factor, and these data suggest that measuring Lp(a) in youth would help identify individuals at higher risk for future ASCVD. Although Lp(a) levels cannot be modified by lifestyle or diet, it appears to be important to emphasize heart-healthy lifestyle choices if elevated levels are detected during childhood.

Automating Echo AI

Check out this Imaging Wire Show featuring Us2.ai’s co-founders, James Hare and Carolyn Lam MBBS, PhD, detailing Us2.ai’s unique origins, impressive capabilities, and big goals to automate echocardiography reporting across the world.

HeartFlow FFRct’s Clinical Data Foundation

HeartFlow FFRct Analysis’ widespread payor support and adoption by 80% of the top 50 US heart hospitals is built on a deep foundation of peer-reviewed clinical research. See how HeartFlow FFRct has consistently proven to reduce unnecessary angiograms and the cost of care, making it a “game changer” for its users. 

The Wire

• Ardent & BioIntelliSense: Ardent Health Services is collaborating with BioIntelliSense to roll out wearables for continuous inpatient monitoring across Ardent’s 30 hospitals. The partnership utilizes BioIntelliSense’s BioButton wearable device and BioCloud analytics engine to automate the collection of inpatient vitals and provide clinicians with more information to help proactive decision-making. The BioButton can take 1,440 vital sign measurements per day, including heart rate, respiratory rate, and skin temperature. 

• How Marital Status Impacts Heart Attack Recovery: A study of nearly 20k acute myocardial infarction patients suggests being unmarried is tied to less reperfusion treatment and a worse long-term prognosis after AMI. Not being married was not associated with worse in-hospital outcomes, but was tied to about a 30% higher risk of death and adverse cardiac and cerebrovascular events during the two years following the AMI. Unmarried people were also only half as likely to receive reperfusion treatment.

• HeartVista Becomes Vista.ai: HeartVista announced its rebranding to Vista.ai, as the post-processing software company expands beyond cardiac MRI, starting with prostate and MSK MRI solutions. Vista.ai’s One Click MRI acquisition software automates the MRI exam workflow, reducing complexity and improving speed and image consistency.

• Telehealth Flexibility Preferences: An AHIP survey found that 82% of adults with employer-provided health coverage are in favor of Congress extending pandemic telehealth flexibilities. Of the 818 respondents, a majority of both Democrats (95%) and Republicans (70%) wanted to extend teleflexibilities, citing reasons such as convenience (49%) and less traveling (35%).

• A New Way to Measure CV Risk Factor: Higher levels of lead in bones and blood are associated with increased risk of CVD mortality. In this prospective study, the authors found they were able to estimate lead concentrations in the tibia, patella, and blood using genome-wide DNA methylation data from 2.3k Americans. While the biomarkers were not associated with CVD incidence, they were associated with CVD mortality. The association between the tibia lead epigenetic biomarker and CVD mortality was modified by sex, with men at increased risk compared with women.

• CB Insights Digital Health 150: CB Insights released its annual Digital Health 150 rankings of the “most promising” private digital health startups, with the finalists selected from a pool of over 13k applicants based on their competitive positioning and momentum, among other metrics. It was cool to see some high flying cardiology up-and-comers make the list, such as Eko (digital stethoscopes), Idoven (cardiology-as-a-service platform), and Ligence (echo automation). For a full analysis of this year’s CB Insights 150, check out this Digital Health Wire deep dive.

• Ultromics EchoGo HF FDA: Ultromics announced the FDA clearance of its EchoGo Heart Failure solution, which identifies patients with HFpEF using a single echo image. This appears to be a high-priority product for Ultromics, which got its start with AI-automated echo reporting, but has directed more of its attention to heart failure detection in 2022. That shift might prove wise, given HFpEF’s prevalence, historic challenges diagnosing the disease, and mounting evidence that HFpEF treatments are effective.

• Shingles & Long-Term CV Risk: In a large study of 200k adults published in JAHA, researchers found that herpes zoster, commonly known as “shingles,” is associated with higher long-term risk of a major cardiovascular event. During more than 2 million person-years of follow-up, herpes zoster was associated with an almost 30% higher long-term risk of a major CV event, and it appears that the risk may persist for over 12 years following an outbreak. 

• Medical Jargon Confusion: A JAMA study highlights how commonly medical jargon confuses patients, sometimes resulting in them taking away a meaning that’s the exact opposite of what was intended. Although 96% of the 215 respondents knew that having a negative cancer screening meant they did not have cancer, only 67% knew that “positive nodes” meant that the cancer had spread. The top phrases to avoid were “grossly intact” for a good neuro exam or “impressive results” when something turns up on an X-ray.

• New 2023 CPT Codes: New CPT codes have officially been announced for 2023. Remote therapeutic monitoring codes were expanded to include codes for the first 20 minutes of treatment management services (98980) and each additional 20 minutes thereafter (98981). Digital ophthalmology received support for remote treatment of amblyopia using an eye-tracking device, as well as technical support, interpretation, and reporting (0704T–0706T). The last codes related to the digitization of glass microscope slides, enabling remote examination by the pathologist or supporting the use of AI (0751T–0763T). 

Defining Heart Disease 

AHA 2022 brought another reminder that Cleerly is ushering the field of cardiology away from population-based estimates into precision heart care. Take a peek at research underway that demonstrates how Cleerly leverages CTA and AI analysis to identify lipid-rich plaque and high-risk arterial buildup. 

Transformation Through Structured Reporting

Ready to realize the benefits of cardiovascular imaging structured reporting? Check out these quick and powerful Change Healthcare videos detailing the efficiency gains provided by structured reporting and what it takes to drive adoption.